People with IBS say it works a dream and they wouldn’t travel far without it. Some have even found that their hayfever symptoms have gone, which suggests there is still a lot we don’t understand about the complex interactions between the gut, immune system and the rest of the body. In young children with acute infectious diarrhoea, it is important to provide rehydration therapy. Although ORS can alleviate dehydration, it has no effect on the duration of diarrhoea or abdominal pain. 5 Thus, Enterosgel may have an additional benefit, especially in vulnerable groups; for example, children and elderly or immunocompromised/renal dialysis/receiving chemotherapy where more rapid resolution of diarrhoeal symptoms could have a beneficial impact on health. Take the necessary dose of ENTEROSGEL® after the first loose stool. Take ENTEROSGEL® at least 2 hours before or after taking oral medications. Take ENTEROSGEL® at least 1–2 hours before or after meal. Dilute the dose in the water of room temperature before its administration. Use sachet immediately after opening. After 16 weeks if patients reported adequate relief of their IBS-D symptoms, they were then asked some questions about their symptoms and Enterosgel use.

Enterosgel | Official Website | Drug-Free IBS Reviews – Enterosgel | Official Website | Drug-Free IBS

Enterosgel is free from preservatives, gluten, sugar, sweeteners, lactose, fat, flavours, colouring, plant or animal-derived ingredients.Enterosgel may affect the absorption of some medicines that are administered orally – use Enterosgel 2 hours before or after taking oral medication. If you are taking any medication, you may wish to consult with your doctor or pharmacist regarding taking Enterosgel. This was a randomised, controlled, multicentre pragmatic study to assess efficacy, tolerability and safety of Enterosgel in the treatment of acute diarrhoea in adults compared with standard care. In line with many medical device studies, the use of a placebo is rare, most studies compare to approved therapies. The specific gel-like formulation and organoleptic properties of Enterosgel are difficult to simulate in a placebo, which is both safe and has no impact on the study outcomes. Hence, this was a pragmatic study utilising patient-reported outcomes compared with NICE guidance standard of care. There were no statistically significant differences between groups for secondary outcomes, that is, the duration of diarrhoea defined as the time until the last liquid stool, percentage of patients with diarrhoea resolved from 12 hours to day 3, stool frequency or duration of nausea, vomiting, fever or abdominal pain. However, there was a trend towards shorter duration in the resolution of diarrhoea in the Enterosgel group (25.3 hours vs 38.4 hours), although this was not statistically significant (p=0.20), possibly due to being underpowered.

Enterosgel in the treatment of Irritable Bowel Syndrome with Enterosgel in the treatment of Irritable Bowel Syndrome with

Enterosgel ® was a game changer for me. Within a week I was down to just a few trips to the bathroom per day, which was an 85% reduction in my symptoms. There has been a complete reversal in my professional life and I have begun having a social life and have been able to go on holiday. None of this was possible before the trial.” UK’s first virtual trial for IBS patients Since eligibility was assessed according to the current Rome IV criteria, the applicability of our findings to the estimated 50% of patients with IBS not matching the Rome IV criteria, 34 including those with milder pain, is not known. We may, however, have mitigated for these patients by recruiting a proportion of cases directly from the community setting and when we reduced the eligibility abdominal pain score at screening to lower screening failures.

Log in/register

The Enterosgel group had a higher percentage of patients (37%) that were positive for the primary endpoint (showed a decrease in both abdominal pain and stool consistency) compared to the placebo (24%). The Enterosgel group also had a higher percentage of patients (53%) with a reduction of abdominal pain compared to 40% to the placebo group.

Virtual trial discovers all-in-one treatment for patients

Yes, Enterosgel is safe for children and is well-tolerated. Enterosgel has an excellent tolerability and safety record during 30 years of use. There have been no reports of severe side effects. The clinical studies in children have shown the effectiveness and safety of the product. For children 1-3 years old it is advisable to consult a doctor prior to use of Enterosgel.

🍪 Privacy & Transparency

Division of Diabetes, Endocrinology and Gastroenterology, The University of Manchester, Manchester, UK